Lincoln Pharmaceuticals informs about standalone and consolidated financial results

21 Jun 2018 Evaluate

Pursuant to Regulation 33(3)(b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lincoln Pharmaceuticals has informed that the Company will continue to submit Quarterly /Year to Date Standalone and Consolidated Financial Results for the Financial Year 2018-19.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

483.20 5.65 (1.18%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.75
Dr. Reddys Lab 1271.05
Cipla 1510.90
Zydus Lifesciences 914.65
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×